Therapixel

company

About

Therapixel is a software company specialized in artificial intelligence for medical imaging analysis

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
€15M
Industries
Artificial Intelligence,Health Diagnostics,Machine Learning,Medical Device,Software
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

Therapixel develops and commercializes AI-based software for breast cancer detection and characterization

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€15.60M
Therapixel has raised a total of €15.60M in funding over 2 rounds. Their latest funding was raised on May 12, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 12, 2022 Series B €15M 1 Detail
Nov 24, 2015 Seed €600K 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Therapixel is funded by 2 investors. Verve Ventures and Conseil Plus Gestion are the most recent investors.
Investor Name Lead Investor Funding Round
Verve Ventures Series B
Conseil Plus Gestion Seed